NCT05557474View on ClinicalTrials.gov

Development and Clinical Validation of Early-stage Lung Cancer Prognostic Kit

RecruitingOBSERVATIONAL
Enrollment

236

Participants

Timeline

Start Date

October 1, 2021

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2028

Conditions
Lung CancerSurgeryRecurrence
Interventions
OTHER

Early-stage lung cancer prognostic kit -- ELISA

blood sample with ELISA

OTHER

Early-stage lung cancer prognostic kit -- IHC

surgical tumor part with IHC

Trial Locations (2)

106

RECRUITING

National Taiwan University, Cancer Center, Taipei

402

RECRUITING

Chung Shan Medical University Hospital, Taichung

All Listed Sponsors
collaborator

National Science and Technology Council

FED

lead

Chung Shan Medical University

OTHER